Back to top
more

Bausch Health Cos Inc. (BHC)

(Delayed Data from NYSE)

$22.86 USD

22.86
2,989,933

+0.32 (1.42%)

Updated Oct 21, 2019 03:56 PM ET

After-Market: $22.86 0.00 (0.00%) 6:45 PM ET

Add to portfolio

3-Hold     3    

This is our short term rating system that serves as a timeliness indicator for stocks over the next 1 to 3 months. How good is it? See rankings and related performance below.

Zacks Rank Definition Annualized Return
1
2
3
4
5
S&P
Strong Buy
Buy
Hold
Sell
Strong Sell
500
24.50%
17.69%
9.28%
4.86%
1.63%
10.50%

Zacks Rank Education - Learn about the Zacks Rank

Zacks Rank Home - Zacks Rank resources in one place

Zacks Premium - The only way to fully access the Zacks Rank

A Value | D Growth | D Momentum | C VGM

The Style Scores are a complementary set of indicators to use alongside the Zacks Rank. It allows the user to better focus on the stocks that are the best fit for his or her personal trading style.

The scores are based on the trading styles of Value, Growth, and Momentum. There's also a VGM Score ('V' for Value, 'G' for Growth and 'M' for Momentum), which combines the weighted average of the individual style scores into one score.

Value Score A
Growth Score A
Momentum Score A
VGM Score A

Within each Score, stocks are graded into five groups: A, B, C, D and F. As you might remember from your school days, an A, is better than a B; a B is better than a C; a C is better than a D; and a D is better than an F.

As an investor, you want to buy stocks with the highest probability of success. That means you want to buy stocks with a Zacks Rank #1 or #2, Strong Buy or Buy, which also has a Score of an A or a B in your personal trading style.

Zacks Style Scores Education - Learn more about the Zacks Style Scores

View All Zacks #1 Ranked Stocks

Trades from $1

The Zacks Equity Research reports, or ZER for short, are our in-house, independently produced research reports.

The ever popular one-page Snapshot reports are generated for virtually every single Zacks Ranked stock. It's packed with all of the company's key stats and salient decision making information. Including the Zacks Rank, Zacks Industry Rank, Style Scores, the Price, Consensus & Surprise chart, graphical estimate analysis and how a stocks stacks up to its peers.

The detailed multi-page Analyst report does an even deeper dive on the company's vital statistics. In addition to all of the proprietary analysis in the Snapshot, the report also visually displays the four components of the Zacks Rank (Agreement, Magnitude, Upside and Surprise); provides a comprehensive overview of the company business drivers, complete with earnings and sales charts; a recap of their last earnings report; and a bulleted list of reasons to buy or sell the stock. It also includes an industry comparison table to see how your stock compares to its expanded industry, and the S&P 500.

Researching stocks has never been so easy or insightful as with the ZER Analyst and Snapshot reports.

Learn more about Zacks Equity Research reports

See more Zacks Equity Research reports

The Zacks Industry Rank assigns a rating to each of the 265 X (Expanded) Industries based on their average Zacks Rank.

An industry with a larger percentage of Zacks Rank #1's and #2's will have a better average Zacks Rank than one with a larger percentage of Zacks Rank #4's and #5's.

The industry with the best average Zacks Rank would be considered the top industry (1 out of 265), which would place it in the top 1% of Zacks Ranked Industries. The industry with the worst average Zacks Rank (265 out of 265) would place in the bottom 1%.

Zacks Rank Education -- Learn more about the Zacks Rank
Zacks Industry Rank Education -- Learn more about the Zacks Industry Rank

Balance Sheet

The Style Scores are a complementary set of indicators to use alongside the Zacks Rank. It allows the user to better focus on the stocks that are the best fit for his or her personal trading style.

The scores are based on the trading styles of Value, Growth, and Momentum. There's also a VGM Score ('V' for Value, 'G' for Growth and 'M' for Momentum), which combines the weighted average of the individual style scores into one score.

Value Score A
Growth Score A
Momentum Score A
VGM Score A

Within each Score, stocks are graded into five groups: A, B, C, D and F. As you might remember from your school days, an A, is better than a B; a B is better than a C; a C is better than a D; and a D is better than an F.

As an investor, you want to buy stocks with the highest probability of success. That means you want to buy stocks with a Zacks Rank #1 or #2, Strong Buy or Buy, which also has a Score of an A or a B in your personal trading style.

Zacks Style Scores Education - Learn more about the Zacks Style Scores

Research for BHC

   

The Zacks Equity Research reports, or ZER for short, are our in-house, independently produced research reports.

The ever popular one-page Snapshot reports are generated for virtually every single Zacks Ranked stock. It's packed with all of the company's key stats and salient decision making information. Including the Zacks Rank, Zacks Industry Rank, Style Scores, the Price, Consensus & Surprise chart, graphical estimate analysis and how a stocks stacks up to its peers.

The detailed multi-page Analyst report does an even deeper dive on the company's vital statistics. In addition to all of the proprietary analysis in the Snapshot, the report also visually displays the four components of the Zacks Rank (Agreement, Magnitude, Upside and Surprise); provides a comprehensive overview of the company business drivers, complete with earnings and sales charts; a recap of their last earnings report; and a bulleted list of reasons to buy or sell the stock. It also includes an industry comparison table to see how your stock compares to its expanded industry, and the S&P 500.

Researching stocks has never been so easy or insightful as with the ZER Analyst and Snapshot reports.

Learn more about Zacks Equity Research reports

See more Zacks Equity Research reports

Fiscal Year End for Bausch Health Cos Inc. falls in the month of December.

All items in Millions except Per Share data.

12/31/2018 12/31/2017 12/31/2016 12/31/2015 12/31/2014
Assets          
Cash & Equivalents 723 797 542 597 323
Receivables 1,865 2,130 2,517 2,687 2,076
Notes Receivable 0 0 0 0 0
Inventories 934 1,048 1,061 1,257 951
Other Current Assets 689 771 957 966 844
Total Current Assets 4,211 4,746 5,077 5,507 4,193
Net Property & Equipment 1,353 1,403 1,312 1,442 1,311
Investments & Advances 0 0 0 0 0
Other Non-Current Assets 0 0 0 0 0
Deferred Charges 1,676 433 146 156 54
Intangibles 25,143 30,804 34,678 41,636 20,602
Deposits & Other Assets 109 111 2,316 224 193
Total Assets 32,492 37,497 43,529 48,965 26,353
Liabilities & Shareholders Equity 12/31/2018 12/31/2017 12/31/2016 12/31/2015 12/31/2014
Notes Payable 0 0 0 0 0
Accounts Payable 411 365 324 434 398
Current Portion Long-Term Debt 228 209 1 823 1
Current Portion Capital Leases 0 0 0 0 0
Accrued Expenses 3,197 3,694 3,175 3,859 2,179
Income Taxes Payable 0 0 0 0 11
Other Current Liabilities 0 0 109 197 142
Total Current Liabilities 3,836 4,268 3,609 5,313 2,731
Mortgages 0 0 0 0 0
Deferred Taxes/Income 885 1,180 5,434 5,902 2,228
Convertible Debt 0 0 0 0 0
Long-Term Debt 24,077 25,235 29,845 30,265 15,254
Non-Current Capital Leases 0 0 0 0 0
Other Non-Current Liabilities 879 870 1,383 1,454 707
Minority Interest (Liabilities) 0 0 0 0 0
Total Liabilities 29,677 31,553 40,271 42,935 20,919
Shareholders Equity 12/31/2018 12/31/2017 12/31/2016 12/31/2015 12/31/2014
Preferred Stock 0 0 0 0 0
Common Stock (Par) 10,121 10,090 10,038 9,897 8,349
Capital Surplus 413 380 351 305 244
Retained Earnings -5,664 -2,725 -5,129 -2,750 -2,365
Other Equity -2,055 -1,801 -2,002 -1,423 -794
Treasury Stock 0 0 0 0 0
Total Shareholder's Equity 2,815 5,944 3,258 6,030 5,435
Total Liabilities & Shareholder's Equity 32,492 37,497 43,529 48,965 26,353
Total Common Equity 2,815 5,944 3,258 6,030 5,435
Shares Outstanding 349.70 348.50 347.60 341.10 335.60
Book Value Per Share 8.05 17.06 9.37 17.68 16.19

Fiscal Year End for Bausch Health Cos Inc. falls in the month of December.

All items in Millions except Per Share data.

9/30/2019 6/30/2019 3/31/2019 12/31/2018 9/30/2018
Assets          
Cash & Equivalents NA 880 784 723 973
Receivables NA 1,829 1,786 1,865 2,041
Notes Receivable NA 0 0 0 0
Inventories NA 1,060 1,012 934 971
Other Current Assets NA 698 693 689 757
Total Current Assets NA 4,467 4,275 4,211 4,742
Net Property & Equipment NA 1,372 1,341 1,353 1,341
Investments & Advances NA 0 0 0 0
Other Non-Current Assets NA 0 0 0 0
Deferred Charges NA 1,799 1,754 1,676 1,641
Intangibles NA 24,356 24,804 25,143 25,945
Deposits & Other Assets NA 360 377 109 108
Total Assets NA 32,354 32,551 32,492 33,777
Liabilities & Shareholders Equity 9/30/2019 6/30/2019 3/31/2019 12/31/2018 9/30/2018
Notes Payable NA 0 0 0 0
Accounts Payable NA 527 429 411 440
Current Portion Long-Term Debt NA 56 257 228 298
Current Portion Capital Leases NA 0 0 0 0
Accrued Expenses NA 3,122 3,255 3,197 3,424
Income Taxes Payable NA 0 0 0 0
Other Current Liabilities NA 0 0 0 0
Total Current Liabilities NA 3,705 3,941 3,836 4,162
Mortgages NA 0 0 0 0
Deferred Taxes/Income NA 884 880 885 1,131
Convertible Debt NA 0 0 0 0
Long-Term Debt NA 24,023 23,924 24,077 24,433
Non-Current Capital Leases NA 0 0 0 0
Other Non-Current Liabilities NA 1,027 879 814
Minority Interest (Liabilities) NA 0 0 0 0
Total Liabilities NA 29,666 29,772 29,677 30,540
Shareholders Equity 9/30/2019 6/30/2019 3/31/2019 12/31/2018 9/30/2018
Preferred Stock NA 0 0 0 0
Common Stock (Par) NA 10,165 10,151 10,121 10,117
Capital Surplus NA 384 374 413 409
Retained Earnings NA -5,887 -5,716 -5,664 -5,320
Other Equity NA -1,974 -2,030 -2,055 -1,969
Treasury Stock NA 0 0 0 0
Total Shareholder's Equity NA 2,688 2,779 2,815 3,237
Total Liabilities & Shareholder's Equity NA 32,354 32,551 32,492 33,777
Total Common Equity 0 2,688 2,779 2,815 3,237
Shares Outstanding 351.80 351.80 349.70 349.70 349.60
Book Value Per Share 0.00 7.64 7.95 8.05 9.26